| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8815911 | Journal of Affective Disorders | 2018 | 27 Pages |
Abstract
Extant data suggest that antidepressant treatment improves workplace outcomes in MDD. The capability of antidepressants in improving measures of workplace functioning should be considered in cost-benefit analyses to better inform cost-modelling studies pertaining to antidepressant therapy.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Psychiatry and Mental Health
Authors
Yena Lee, Joshua D. Rosenblat, JungGoo Lee, Nicole E. Carmona, Mehala Subramaniapillai, Margarita Shekotikhina, Rodrigo B. Mansur, Elisa Brietzke, Jae-Hon Lee, Roger C. Ho, Samantha J. Yim, Roger S. McIntyre,